Synonym
FPL-55712 sodium; FPL55712 sodium; FPL 55712 sodium
IUPAC/Chemical Name
7-[3-(4-Acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]- 4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid sodium salt
InChi Key
ZDEVPOBNLIVGFA-UHFFFAOYSA-M
InChi Code
InChI=1S/C27H30O9.Na/c1-4-6-19-22(10-8-17(15(3)28)25(19)31)34-13-16(29)14-35-23-11-9-18-21(30)12-24(27(32)33)36-26(18)20(23)7-5-2;/h8-12,16,29,31H,4-7,13-14H2,1-3H3,(H,32,33);/q;+1/p-1
SMILES Code
O=C(C1=CC(C2=CC=C(OCC(O)COC3=CC=C(C(C)=O)C(O)=C3CCC)C(CCC)=C2O1)=O)[O-].[Na+]
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
520.51
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Busch L, Miozza V, Sterin-Borda L, Borda E. Increased leukotriene concentration in submandibular glands from rats with experimental periodontitis. Inflamm Res. 2009 Jul;58(7):423-30. doi: 10.1007/s00011-009-0008-8. Epub 2009 Apr 4. PubMed PMID: 19347252.
2: Montuschi P. Leukotrienes, antileukotrienes and asthma. Mini Rev Med Chem. 2008 Jun;8(7):647-56. Review. Erratum in: Mini Rev Med Chem. 2008 Sep;8(10):1064. PubMed PMID: 18537720.
3: Buccellati C, Fumagalli F, Viappiani S, Folco G. Leukotriene modifiers: novel therapeutic opportunities in asthma. Farmaco. 2002 Mar;57(3):235-42. Review. PubMed PMID: 11989802.
4: Young RN. Discovery of montelukast: a once-a-day oral antagonist of leukotriene D4 for the treatment of chronic asthma. Prog Med Chem. 2001;38:249-77. Review. PubMed PMID: 11774796.
5: Lai YL, Lee CF. Mediators and oxygen radicals in hyperpnea-induced airway constriction of guinea pigs. Lung. 2000;178(4):213-23. PubMed PMID: 10960556.
6: Hamanaka N, Nakai H. [Leukotriene D4 antagonists]. Tanpakushitsu Kakusan Koso. 2000 Apr;45(6 Suppl):967-72. Review. Japanese. PubMed PMID: 10771659.
7: Lai YL, Lee SP. Mediators in hyperpnea-induced bronchoconstriction of guinea pigs. Naunyn Schmiedebergs Arch Pharmacol. 1999 Nov;360(5):597-602. PubMed PMID: 10598800.
8: Nicosia S. Pharmacodynamic properties of leukotriene receptor antagonists. Monaldi Arch Chest Dis. 1999 Jun;54(3):242-6. Review. PubMed PMID: 10441979.
9: Takami M, Tsukada W. In vitro effect of DP-1904, a novel anti-asthma agent, against antigen-induced constriction and TXB2 release from the isolated guinea-pig lung parenchymal tissue. Pharmacol Res. 1998 Aug;38(2):141-7. PubMed PMID: 9721602.
10: Marcelle R. Leukotrienes antagonist-inhibitor and the bronchial response to inhaled antigen in actively sensitized guinea-pigs. Arch Physiol Biochem. 1998 Aug;105(4):358-64. PubMed PMID: 9711356.
11: Bernstein PR. Chemistry and structure--activity relationships of leukotriene receptor antagonists. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 2):S220-5; discussion S225-6, S247-8. Review. PubMed PMID: 9647603.
12: Bernstein PR. Chemistry and structure-activity relationships of leukotriene receptor antagonists . Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):S220-6. PubMed PMID: 9620943.
13: Sampson A, Holgate S. Leukotriene modifiers in the treatment of asthma. Look promising across the board of asthma severity. BMJ. 1998 Apr 25;316(7140):1257-8. PubMed PMID: 9554892; PubMed Central PMCID: PMC1113026.
14: Shizawa T, Maeda K, Abe K, Ishii T, Kamitani T. Effects of TMK688, a novel anti-allergic drug, on allergic nasal obstruction and exudative responses in sensitized guinea pigs. Naunyn Schmiedebergs Arch Pharmacol. 1997 Dec;356(6):815-9. PubMed PMID: 9453468.
15: Shekher A, Singh M. Role of eicosanoid inhibition of ischemia reperfusion injury: intact and isolated rat heart studies. Methods Find Exp Clin Pharmacol. 1997 May;19(4):223-9. PubMed PMID: 9228647.
16: Nuessler V, Pelka-Fleischer R, Zwierzina H, Wilmanns W, Denzlinger C. Effects of progesterone and leukotriene receptor antagonists in experimental models of P-glycoprotein-related resistance. Eur J Med Res. 1997 Apr 21;2(4):159-64. PubMed PMID: 9110922.
17: Zhang MQ, Timmerman H. Leukotriene cysLT1 (LTD4) receptor antagonism of H1-antihistamines: an in vitro study. Inflamm Res. 1997 Mar;46 Suppl 1:S93-4. PubMed PMID: 9098782.
18: Pfeifer M, Muders F, Luchner A, Blumberg F, Riegger GA, Elsner D. Leukotriene receptor blockade in experimental heart failure. Res Exp Med (Berl). 1997;197(4):177-87. PubMed PMID: 9440136.
19: Przylipiak A, Rabe T, Kiesel L, Przylipiak J, Klinga K, Runnebaum B. Role of leukotriene C4 in follicle-stimulating hormone (FSH) secretion in female rat pituitary. Gynecol Endocrinol. 1996 Apr;10(2):95-100. PubMed PMID: 8701793.
20: He KQ, Cheng GF, Xi FD, Guo ZR, Zhu XY. [Structure-activity relationship studies of chalcones as SRS-A receptor antagonists]. Yao Xue Xue Bao. 1996;31(11):878-80. Chinese. PubMed PMID: 9863261.
